1604440-58-5

Basic information

• Product Name: (R)-1-((2,4-dimethoxybenzyl)amino)propan-2-ol
• Synonyms: (R)-1-((2,4-dimethoxybenzyl)amino)propan-2-ol
• CAS NO: 1604440-58-5
• Molecular Weight: 225.288
• Mol File: 1604440-58-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (R)-1-((2,4-dimethoxybenzyl)amino)propan-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-((2,4-dimethoxybenzyl)amino)propan-2-ol(1604440-58-5)
• EPA Substance Registry System: (R)-1-((2,4-dimethoxybenzyl)amino)propan-2-ol(1604440-58-5)

Safety Data

• Hazardous Substances Data: 1604440-58-5(Hazardous Substances Data)

Upstream product

• 2799-16-8 (2R)-hydroxypropylamine 
• 613-45-6 2,4-Dimethoxybenzaldehyde 

Downstream Products

• 1623766-31-3 (R)-4-(2,4-dimethoxybenzyl)-2-methyl-3,4-dihydro-1,4-oxazepin-5(2H)-one 
• 1623766-32-4 (R)-4-(2,4-dimethoxybenzyl)-2-methyl-1,4-oxazepan-5-one 
• 1623766-30-2 (R)-N-(2,4-dimethoxybenzyl)-N-(2-hydroxypropyl)-3,3-dimethoxypropanamide 

Relevant articles and documents

Synthesis of oxidative metabolites of K-115, a novel Rho-kinase inhibitor

In humans, oxidative metabolites 2–4 of (S)-4-fluoro-5-(2-methyl-1,4-diazepan-1-ylsulfonyl)-isoquinoline hydrochloride dihydrate (K-115, 1), a novel Rho-kinase inhibitor, are mainly formed by aldehyde oxidase and CYP3A4 / 3A5 in human liver S9 and hepatoc

Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative

A compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof works as an mGluR2 antagonist, and is applicable as a therapeutic agent for neurological disorders related to glutamate dysfunction and diseases involving th